SINTA - Science and Technology Index

HENDRIK SETIA BUDI

Universitas Airlangga S1 - Kedokteran Gigi SINTA ID : 257561

2.566

SINTA Score Overall

679

SINTA Score 3Yr

2.566

Affil Score

679

Affil Score 3Yr

Latest number of activities

OSSEOINTEGRATION OF PCL/ MULTI-WALL CARBON NANOTUBE (MWCNT) SCAFFOLDS FOR BONE TISSUE ENGINEERING

Leader : Hendrik Setia Budi PROGRAM PENELITIAN EQUITY ( IRC BY SUBJECT )

Personils : Aqsa Sjuhada Oki; Oki Fadhila;

2025 Rp. 149.951.015 Approved INTERNAL SOURCE

GROWTH FACTORS OPTIMISATION IN NANOEMULGEL DELIVERY OF SHED-DERIVED CONDITIONED MEDIUM AS A BIOTHERAPY CANDIDATE

Leader : Hendrik Setia Budi AIRLANGGA RESEARCH FUND BATCH 1 TAHUN 2025 ( IRC TOP OVER #300 )

Personils : Prawati Nuraini;

2025 Rp. 58.548.230 Approved INTERNAL SOURCE

METABOLOMICS AND PROTEOMIC ANALYSIS OF THE STEM CELLS FROM HUMAN EXFOLIATED DECIDUOUS TEETH – CONDITIONED MEDIUM FOR TISSUE ENGINEERING

Leader : Hendrik Setia Budi PROGRAM PENELITIAN EQUITY ( IRN EQUITY )

Personils : Yuliati; Oki Fadhila;

2025 Rp. 149.924.430 Approved INTERNAL SOURCE

Optimalisasi Scaffold Polycaprolactone/Graphene dengan Sekretom SHED untuk Meningkatkan Regenerasi Tulang Secara Inovatif

Leader : Silvia Anitasari Penelitian Kompetitif Nasional ( PFR )

Personils : Sylvia Agustin; Nataniel Tandirogang; Hendrik Setia Budi;

2025 Rp. 135.690.000 Approved BIMA SOURCE

IMUNOMODULATOR SCAFFOLD POLYCAPROLACTONE/GRAPHENE PADA KULTUR SEL PUNCA PULPA GIGI SULUNG (SHED) DAN DEFEK HEWAN MODEL SEBAGAI KANDIDAT BIOMATERIAL PENGINDUKSI OSTEOGENESIS DAN ANGIOGENESIS

Leader : Hendrik Setia Budi PENELITIAN FUNDAMENTAL ( PF )

Personils : Silvia Anitasari;

2024 Rp. 143.400.000 Approved INTERNAL SOURCE

IN SILICO, MOLECULAR DOCKING AND IN VITRO ANTIMICROBIAL PROPERTIES OF POLY-E-CAPROLACTONE/GRAPHENE 3D SCAFFOLD FOR BONE TISSUE ENGINEERING

Leader : Hendrik Setia Budi AIRLANGGA RESEARCH FUND ( IRC TOP #300 )

Personils : Tantiana;

2024 Rp. 90.713.547 Approved INTERNAL SOURCE

Peran imunomodulator biomaterial scaffold polycaprolactone/graphene untuk terapi defek tulang melalui mekanisme osteogenesis dan angiogenesis

Leader : Hendrik Setia Budi Penelitian Kompetitif Nasional ( PFR )

Personils : An Nissa Chusida; Silvia Anitasari;

2024 Rp. 143.400.000 Approved BIMA SOURCE

KARAKTERISASI CAMPURAN POLYMETHYL METHACRYLATE DAN HIDROXYAPATITE SEBAGAI BAHAN ALTERNATIF UNTUK INOVASI PEMBUATAN IMPLAN GIGI

Leader : Rini Devijanti Ridwan AIRLANGGA RESEARCH FUND ( PDDA )

Personils : Hendrik Setia Budi;

2024 Rp. 49.250.000 Approved INTERNAL SOURCE

PENGEMBANGAN KIT DETEKSI MAKANAN NON-HALAL YANG CEPAT DAN MUDAH PADA MASYARAKAT

Leader : Hendrik Setia Budi PENELITIAN UNGGULAN HALAL ( PUH )

Personils : Tantiana;

2024 Rp. 41.762.068 Approved INTERNAL SOURCE

ANALISA SPENT MEDIA DARI STEM CELLS FROM HUMAN EXFOLIATED DECIDUOUS TEETH (SHED) SEBAGAI BIOTHERAPY

Leader : Hendrik Setia Budi RISET KOLABORASI INDONESIA ( RKI )

Personils : -

2024 Rp. 100.000.000 Approved INTERNAL SOURCE

	Scopus	GScholar	WOS
Article	82	129	26
Citation	969	1543	419
Cited Document	63	74	23
H-Index	16	20	12
i10-Index	25	36	15
G-Index	1	1	1

HENDRIK SETIA BUDI

Summary